Breast cancer may be several diseases

Physicians have come to understand that what we call breast cancer is really several — probably at least five — different diseases that need different treatments and have different outcomes. Now researchers at the School of Medicine and collaborating institutions in the United States and Canada plan to evaluate these breast cancer subtypes and determine the likely prognosis and most effective treatment for each.

Tumor cells that border normal tissue are told to leave

The thin, single-cell boundary where a tumor meets normal tissue is the most dangerous part of a cancer according to a new study by scientists at the School of Medicine. The researchers found that tumor cells bordering normal tissue receive signals that tell them to wander away from the tumor, allowing the cancer cells to establish deadly metastatic tumors elsewhere in the body.

January 2006 Radio Service

Listed below are this month’s featured news stories. • Non-visual functions of the eye (week of Jan. 4) • Calorie restriction dieting (week of Jan. 11) • Alzheimer’s gene (week of Jan. 18) • Genes and side effects (week of Jan. 25)

Variation in bitter-taste receptor gene increases risk for alcoholism

Alcoholism may be linked to taste.A team of researchers, led by investigators at the School of Medicine, has found that a gene variant for a bitter-taste receptor on the tongue is associated with an increased risk for alcohol dependence. The research team studied DNA samples from 262 families, all of which have at least three alcoholic individuals. Investigators report in the January issue of the American Journal of Human Genetics on the variation in a taste receptor gene on chromosome 7 called TAS2R16.

Preferred treatment method for advanced ovarian cancer announced

The National Cancer Institute (NCI), part of the National Institutes of Health, issued an announcement encouraging treatment with anticancer drugs via two methods, after surgery, for women with advanced ovarian cancer. The combined methods, which deliver drugs into a vein and directly into the abdomen, extend overall survival for women with advanced ovarian cancer by about a year. The Siteman Cancer Center at the School of Medicine and Barnes-Jewish Hospital participated in the NCI-supported clinical trial which led to this clinical announcement.

Genes’ influence on common drugs may affect health-care quality, cost

Chances are good that a medication you take is one of several drugs that can be affected by genetic factors, according to researchers at the School of Medicine and the St. Louis College of Pharmacy. They found that 29 percent of patients seen at local primary-care offices had taken at least one of 16 drugs that can cause adverse reactions in genetically susceptible people.
View More Stories